Healthcare >> CEO Interviews >> April 8, 2014
Dr. John Bonfiglio is Chief Executive Officer and President of Oragenics Inc. Most recently, Dr. Bonfiglio worked as the President and Chief Executive Officer and as a director of Transdel Pharmaceuticals, Inc. Prior to that, he worked as the President and Chief Executive Officer of Argos Therapeutics in Durham, North Carolina, and prior to that, he was the Chief Executive Officer of The Immune Response Corporation in Carlsbad, California. He was also the Chief Executive Officer of Peregrine Pharmaceuticals and held senior management positions with Cypress Biosciences, Baxter Healthcare and Allergan, Inc. Profile
WST: Please start us off with a brief overview of Oragenics’ business.
Dr. Bonfiglio: Oragenics has been involved since its inception mostly in diseases of the mouth, and we are